In skeletal muscle, they downregulate atrophy-associated genes (MuRF1, MAFbx) and upregulate myogenic factors (MyoD, MyoG), thereby improving perfusion and energy metabolism
Yet, the introduction of oral semaglutide, a modified form of semaglutide with the addition of a carrier sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, may have provided a safe and effective way to reach systemic circulation while other molecules are in development
Weight loss is great, but they still want a youthful face
doi:10.1200/JCO.2026.44.16_suppl.11000 Shah Z, Hundal J, Afridi SS, et al
doi: 10.1056/NEJMoa0806470 4 HolmanRRPaulSKBethelMANeilHAMatthewsDR
2108 participants were randomly assigned to receive cagrilintidesemaglutide, 302 to receive semaglutide alone, 302 to receive cagrilintide alone, and 705 to receive placebo (Fig